Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS

Abstract

MOG-Abs may be a disease-specific biomarker in adult patients with IDD who have a disease distinct from NMO or MS. The radiologic as well as clinical manifestations of MOG-Ab patients can be useful in their differential diagnosis.